{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:42:25Z","timestamp":1779140545588,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","award":["SAF2017-83053-R"],"award-info":[{"award-number":["SAF2017-83053-R"]}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["SAF2016-75500-R"],"award-info":[{"award-number":["SAF2016-75500-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/01102"],"award-info":[{"award-number":["PI13\/01102"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","award":["CB\/07\/09\/0026"],"award-info":[{"award-number":["CB\/07\/09\/0026"]}],"id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","award":["SAM15PINT1514"],"award-info":[{"award-number":["SAM15PINT1514"]}],"id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12035-019-1619-x","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T17:05:38Z","timestamp":1556903138000},"page":"7522-7533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Modulation of Monoaminergic Systems by Antidepressants in the Frontal Cortex of Rats After Chronic Mild Stress Exposure"],"prefix":"10.1007","volume":"56","author":[{"given":"David","family":"Mart\u00edn-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta P.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiram","family":"Tendilla-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L. M.","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Garc\u00eda-Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Leza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8622-749X","authenticated-orcid":false,"given":"Javier R.","family":"Caso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"issue":"15","key":"1619_CR1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1001\/jama.2017.3826","volume":"317","author":"MJ Friedrich","year":"2017","unstructured":"Friedrich MJ (2017) Depression is the leading cause of disability around the world. JAMA 317(15):1517. \n                    https:\/\/doi.org\/10.1001\/jama.2017.3826","journal-title":"JAMA"},{"issue":"7","key":"1619_CR2","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1007\/s12035-016-0032-y","volume":"54","author":"F Ferrari","year":"2017","unstructured":"Ferrari F, Villa RF (2017) The neurobiology of depression: an integrated overview from biological theories to clinical evidence. Mol Neurobiol 54(7):4847\u20134865. \n                    https:\/\/doi.org\/10.1007\/s12035-016-0032-y","journal-title":"Mol Neurobiol"},{"key":"1619_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.65","volume":"2","author":"C Otte","year":"2016","unstructured":"Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF (2016) Major depressive disorder. Nat Rev Dis Primers 2:16065. \n                    https:\/\/doi.org\/10.1038\/nrdp.2016.65","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1619_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pharmthera.2012.09.006","volume":"137","author":"F Artigas","year":"2013","unstructured":"Artigas F (2013) Serotonin receptors involved in antidepressant effects. Pharmacol Ther 137(1):119\u2013131. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2012.09.006","journal-title":"Pharmacol Ther"},{"key":"1619_CR5","unstructured":"Perez, D., et al. Adrenoceptors. Last modified on 10\/08\/2015. Accessed on 19\/11\/2018. IUPHAR\/BPS Guide to PHARMACOLOGY, \n                    http:\/\/www.guidetopharmacology.org\/GRAC\/FamilyIntroductionForward?familyId=4"},{"issue":"2","key":"1619_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.pharep.2015.08.007","volume":"68","author":"K Pytka","year":"2016","unstructured":"Pytka K, Podkowa K, Rapacz A, Podkowa A, Zmudzka E, Olczyk A, Sapa J, Filipek B (2016) The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect. Pharmacol Rep 68(2):263\u2013274. \n                    https:\/\/doi.org\/10.1016\/j.pharep.2015.08.007","journal-title":"Pharmacol Rep"},{"issue":"5","key":"1619_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra035354","volume":"351","author":"RH Belmaker","year":"2004","unstructured":"Belmaker RH (2004) Bipolar disorder. N Engl J Med 351(5):476\u2013486. \n                    https:\/\/doi.org\/10.1056\/NEJMra035354","journal-title":"N Engl J Med"},{"key":"1619_CR8","doi-asserted-by":"publisher","first-page":"212290","DOI":"10.7573\/dic.212290","volume":"4","author":"D Santarsieri","year":"2015","unstructured":"Santarsieri D, Schwartz TL (2015) Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context 4:212290. \n                    https:\/\/doi.org\/10.7573\/dic.212290","journal-title":"Drugs Context"},{"key":"1619_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuropharm.2015.11.029","volume":"103","author":"D Martin-Hernandez","year":"2016","unstructured":"Martin-Hernandez D, Bris AG, MacDowell KS, Garcia-Bueno B, Madrigal JL, Leza JC, Caso JR (2016) Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats. Neuropharmacology 103:79\u201391. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2015.11.029","journal-title":"Neuropharmacology"},{"issue":"12","key":"1619_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.euroneuro.2007.03.010","volume":"17","author":"M Taler","year":"2007","unstructured":"Taler M, Gil-Ad I, Lomnitski L, Korov I, Baharav E, Bar M, Zolokov A, Weizman A (2007) Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol 17(12):774\u2013780. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2007.03.010","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"1619_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/npp.2013.319","volume":"39","author":"AJ Robison","year":"2014","unstructured":"Robison AJ, Vialou V, Sun HS, Labonte B, Golden SA, Dias C, Turecki G, Tamminga C et al (2014) Fluoxetine epigenetically alters the CaMKIIalpha promoter in nucleus accumbens to regulate DeltaFosB binding and antidepressant effects. Neuropsychopharmacology 39(5):1178\u20131186. \n                    https:\/\/doi.org\/10.1038\/npp.2013.319","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1619_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172270","volume":"12","author":"C Zhou","year":"2017","unstructured":"Zhou C, Zhong J, Zou B, Fang L, Chen J, Deng X, Zhang L, Zhao X et al (2017) Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PLoS One 12(2):e0172270. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0172270","journal-title":"PLoS One"},{"issue":"2","key":"1619_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11064-010-0331-z","volume":"36","author":"W Abdel-Razaq","year":"2011","unstructured":"Abdel-Razaq W, Kendall DA, Bates TE (2011) The effects of antidepressants on mitochondrial function in a model cell system and isolated mitochondria. Neurochem Res 36(2):327\u2013338. \n                    https:\/\/doi.org\/10.1007\/s11064-010-0331-z","journal-title":"Neurochem Res"},{"issue":"1","key":"1619_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/187152409787601897","volume":"9","author":"S Hashioka","year":"2009","unstructured":"Hashioka S, McGeer PL, Monji A, Kanba S (2009) Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer\u2019s disease. Cent Nerv Syst Agents Med Chem 9(1):12\u201319","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"1619_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000087097","volume":"52","author":"P Willner","year":"2005","unstructured":"Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90\u2013110. \n                    https:\/\/doi.org\/10.1159\/000087097","journal-title":"Neuropsychobiology"},{"key":"1619_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/ALN.0b013e3182657b3e","volume":"117","author":"L Bravo","year":"2012","unstructured":"Bravo L, Mico JA, Rey-Brea R, P\u00e9rez-Nievas B, Leza JC, Berrocoso E (2012) Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression. Anesthesiology 117:613\u2013625. \n                    https:\/\/doi.org\/10.1097\/ALN.0b013e3182657b3e","journal-title":"Anesthesiology"},{"issue":"1","key":"1619_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s12035-018-1096-7","volume":"56","author":"D Martin-Hernandez","year":"2019","unstructured":"Martin-Hernandez D, Tendilla-Beltran H, Madrigal JLM, Garcia-Bueno B, Leza JC, Caso JR (2019) Chronic mild stress alters kynurenine pathways changing the glutamate neurotransmission in frontal cortex of rats. Mol Neurobiol 56(1):490\u2013501. \n                    https:\/\/doi.org\/10.1007\/s12035-018-1096-7","journal-title":"Mol Neurobiol"},{"key":"1619_CR18","first-page":"785","volume":"59","author":"M Ku\u0153mider","year":"2007","unstructured":"Ku\u0153mider M, Solich J, Paach P, Dziedzicka-wasylewska M (2007) Effect of citalopram in the modified forced swim test in rats. Pharmacol Rep 59:785\u2013788","journal-title":"Pharmacol Rep"},{"key":"1619_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s002130050555","volume":"136","author":"J R\u00e9n\u00e9ric","year":"1998","unstructured":"R\u00e9n\u00e9ric J, Lucki I (1998) Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology 136:190\u2013197","journal-title":"Psychopharmacology"},{"key":"1619_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1742-2094-8-151","volume":"8","author":"I G\u00e1rate","year":"2011","unstructured":"G\u00e1rate I, Garc\u00eda-Bueno B, Madrigal JLM, Bravo L, Berrocoso E, Caso JR, Mico JA, Leza JC (2011) Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. J Neuroinflammation 8:151. \n                    https:\/\/doi.org\/10.1186\/1742-2094-8-151","journal-title":"J Neuroinflammation"},{"issue":"15","key":"1619_CR21","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG (2012) Primer3\u2014new capabilities and interfaces. Nucleic Acids Res 40(15):e115. \n                    https:\/\/doi.org\/10.1093\/nar\/gks596","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1619_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D (2002) The human genome browser at UCSC. Genome Res 12(6):996\u20131006. \n                    https:\/\/doi.org\/10.1101\/gr.229102","journal-title":"Genome Res"},{"key":"1619_CR23","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","volume":"37","author":"P Willner","year":"2013","unstructured":"Willner P, Scheel-Kruger J, Belzung C (2013) The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 37:2331\u20132371. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2012.12.007","journal-title":"Neurosci Biobehav Rev"},{"key":"1619_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbr.2015.04.052","volume":"291","author":"XY Deng","year":"2015","unstructured":"Deng XY, Li HY, Chen JJ, Li RP, Qu R, Fu Q, Ma SP (2015) Thymol produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in mice. Behav Brain Res 291:12\u201319. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2015.04.052","journal-title":"Behav Brain Res"},{"issue":"11","key":"1619_CR25","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/ijnp\/pyx062","volume":"20","author":"M Jia","year":"2017","unstructured":"Jia M, Li C, Zheng Y, Ding X, Chen M, Ding J, Du R, Lu M et al (2017) Leonurine exerts antidepressant-like effects in the chronic mild stress-induced depression model in mice by inhibiting neuroinflammation. Int J Neuropsychopharmacol 20(11):886\u2013895. \n                    https:\/\/doi.org\/10.1093\/ijnp\/pyx062","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"1619_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0327(92)90019-3","volume":"24","author":"J Quintana","year":"1992","unstructured":"Quintana J (1992) Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations. J Affect Disord 24(2):55\u201362","journal-title":"J Affect Disord"},{"issue":"4","key":"1619_CR27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.mp.4001949","volume":"12","author":"HG Ruhe","year":"2007","unstructured":"Ruhe HG, Mason NS, Schene AH (2007) Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry 12(4):331\u2013359. \n                    https:\/\/doi.org\/10.1038\/sj.mp.4001949","journal-title":"Mol Psychiatry"},{"issue":"5","key":"1619_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1017\/S1461145708009474","volume":"12","author":"CH West","year":"2009","unstructured":"West CH, Ritchie JC, Boss-Williams KA, Weiss JM (2009) Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons. Int J Neuropsychopharmacol 12(5):627\u2013641. \n                    https:\/\/doi.org\/10.1017\/S1461145708009474","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6316","key":"1619_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/350350a0","volume":"350","author":"T Pacholczyk","year":"1991","unstructured":"Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350(6316):350\u2013354. \n                    https:\/\/doi.org\/10.1038\/350350a0","journal-title":"Nature"},{"issue":"6","key":"1619_CR30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/npp.2008.183","volume":"34","author":"Z Zhao","year":"2009","unstructured":"Zhao Z, Zhang HT, Bootzin E, Millan MJ, O\u2019Donnell JM (2009) Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs. Neuropsychopharmacology 34(6):1467\u20131481. \n                    https:\/\/doi.org\/10.1038\/npp.2008.183","journal-title":"Neuropsychopharmacology"},{"key":"1619_CR31","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/mp.2011.92","volume":"17","author":"A Bortolozzi","year":"2012","unstructured":"Bortolozzi A, Casta\u00f1\u00e9 A, Semakova J, Santana N, Alvarado G, Cort\u00e9s R, Ferr\u00e9s-Coy A, Fern\u00e1ndez G et al (2012) Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects. Mol Psychiatry 17:612\u2013623. \n                    https:\/\/doi.org\/10.1038\/mp.2011.92","journal-title":"Mol Psychiatry"},{"key":"1619_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00213-006-0691-x","volume":"192","author":"ZA Hughes","year":"2007","unstructured":"Hughes ZA, Starr KR, Scott CM, Newson MJ, Sharp T, Watson JM, Hagan JJ, Dawson LA (2007) Simultaneous blockade of 5-HT1A\/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A\/B receptor antagonist\/5-HT transport inhibitor SB-649915-B. Psychopharmacology 192:121\u2013133. \n                    https:\/\/doi.org\/10.1007\/s00213-006-0691-x","journal-title":"Psychopharmacology"},{"issue":"1","key":"1619_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1021\/cn3002174","volume":"4","author":"SC Altieri","year":"2013","unstructured":"Altieri SC, Garcia-Garcia AL, Leonardo ED, Andrews AM (2013) Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behavior. ACS Chem Neurosci 4(1):72\u201383. \n                    https:\/\/doi.org\/10.1021\/cn3002174","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"1619_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0893-133X(96)00242-4","volume":"16","author":"P Blier","year":"1997","unstructured":"Blier P, Bergeron R, de Montigny C (1997) Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology 16(5):333\u2013338. \n                    https:\/\/doi.org\/10.1016\/S0893-133X(96)00242-4","journal-title":"Neuropsychopharmacology"},{"key":"1619_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2018.03.005","volume":"135","author":"J Volle","year":"2018","unstructured":"Volle J, Bregman T, Scott B, Diwan M, Raymond R, Fletcher PJ, Nobrega JN, Hamani C (2018) Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system. Neuropharmacology 135:63\u201372. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2018.03.005","journal-title":"Neuropharmacology"},{"issue":"5","key":"1619_CR36","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.euroneuro.2017.02.011","volume":"27","author":"ER Veldman","year":"2017","unstructured":"Veldman ER, Svedberg MM, Svenningsson P, Lundberg J (2017) Distribution and levels of 5-HT1B receptors in anterior cingulate cortex of patients with bipolar disorder, major depressive disorder and schizophrenia\u2014an autoradiography study. Eur Neuropsychopharmacol 27(5):504\u2013514. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2017.02.011","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"1619_CR37","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/npp.2016.109","volume":"41","author":"KM Nautiyal","year":"2016","unstructured":"Nautiyal KM, Tritschler L, Ahmari SE, David DJ, Gardier AM, Hen R (2016) A lack of serotonin 1B autoreceptors results in decreased anxiety and depression-related behaviors. Neuropsychopharmacology 41(12):2941\u20132950. \n                    https:\/\/doi.org\/10.1038\/npp.2016.109","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1619_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.euroneuro.2015.12.012","volume":"26","author":"SL Diaz","year":"2016","unstructured":"Diaz SL, Narboux-Neme N, Boutourlinsky K, Doly S, Maroteaux L (2016) Mice lacking the serotonin 5-HT2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants. Eur Neuropsychopharmacol 26(2):265\u2013279. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2015.12.012","journal-title":"Eur Neuropsychopharmacol"},{"key":"1619_CR39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pnpbp.2015.12.006","volume":"66","author":"A Chagraoui","year":"2016","unstructured":"Chagraoui A, Thibaut F, Skiba M, Thuillez C, Bourin M (2016) 5-HT2C receptors in psychiatric disorders: a review. Prog Neuro-Psychopharmacol Biol Psychiatry 66:120\u2013135. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2015.12.006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"10","key":"1619_CR40","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/mp.2013.144","volume":"19","author":"MD Opal","year":"2014","unstructured":"Opal MD, Klenotich SC, Morais M, Bessa J, Winkle J, Doukas D, Kay LJ, Sousa N et al (2014) Serotonin 2C receptor antagonists induce fast-onset antidepressant effects. Mol Psychiatry 19(10):1106\u20131114. \n                    https:\/\/doi.org\/10.1038\/mp.2013.144","journal-title":"Mol Psychiatry"},{"issue":"6630","key":"1619_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/387303a0","volume":"387","author":"CM Burns","year":"1997","unstructured":"Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387(6630):303\u2013308. \n                    https:\/\/doi.org\/10.1038\/387303a0","journal-title":"Nature"},{"key":"1619_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neubiorev.2014.03.001","volume":"42","author":"CB Martin","year":"2014","unstructured":"Martin CB, Hamon M, Lanfumey L, Mongeau R (2014) Controversies on the role of 5-HT(2C) receptors in the mechanisms of action of antidepressant drugs. Neurosci Biobehav Rev 42:208\u2013223. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2014.03.001","journal-title":"Neurosci Biobehav Rev"},{"key":"1619_CR43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40263-015-0236-0","volume":"29","author":"A Nikiforuk","year":"2015","unstructured":"Nikiforuk A (2015) Targeting the serotonin 5-HT 7 receptor in the search for treatments for CNS disorders: rationale and progress to date. CNS Drugs 29:265\u2013275. \n                    https:\/\/doi.org\/10.1007\/s40263-015-0236-0","journal-title":"CNS Drugs"},{"issue":"Suppl","key":"1619_CR44","first-page":"S3","volume":"26","author":"P Blier","year":"2001","unstructured":"Blier P (2001) Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response. J Psychiatry Neurosci 26(Suppl):S3\u2013S10","journal-title":"J Psychiatry Neurosci"},{"key":"1619_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pnpbp.2013.01.014","volume":"44","author":"MP Cunha","year":"2013","unstructured":"Cunha MP, Pazini FL, Oliveira A, Bettio LE, Rosa JM, Machado DG, Rodrigues AL (2013) The activation of alpha1-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test. Prog Neuro-Psychopharmacol Biol Psychiatry 44:39\u201350. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2013.01.014","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1619_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2015.01.010","volume":"750","author":"CA Ribeiro","year":"2015","unstructured":"Ribeiro CA, Pupo AS (2015) Involvement of alpha1B-adrenoceptors in the anti-immobility effect of imipramine in the tail suspension test. Eur J Pharmacol 750:39\u201342. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2015.01.010","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1619_CR47","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.tips.2015.02.006","volume":"36","author":"SZ Langer","year":"2015","unstructured":"Langer SZ (2015) alpha2-adrenoceptors in the treatment of major neuropsychiatric disorders. Trends Pharmacol Sci 36(4):196\u2013202. \n                    https:\/\/doi.org\/10.1016\/j.tips.2015.02.006","journal-title":"Trends Pharmacol Sci"},{"issue":"13","key":"1619_CR48","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1523\/JNEUROSCI.21-13-04875.2001","volume":"21","author":"NL Schramm","year":"2001","unstructured":"Schramm NL, McDonald MP, Limbird LE (2001) The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 21(13):4875\u20134882","journal-title":"J Neurosci"},{"key":"1619_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neuroscience.2013.06.058","volume":"250","author":"NM Vega-Rivera","year":"2013","unstructured":"Vega-Rivera NM, Lopez-Rubalcava C, Estrada-Camarena E (2013) The antidepressant-like effect of ethynyl estradiol is mediated by both serotonergic and noradrenergic systems in the forced swimming test. Neuroscience 250:102\u2013111. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2013.06.058","journal-title":"Neuroscience"},{"issue":"7","key":"1619_CR50","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1016\/j.neuropharm.2012.02.011","volume":"62","author":"C Cottingham","year":"2012","unstructured":"Cottingham C, Li X, Wang Q (2012) Noradrenergic antidepressant responses to desipramine in vivo are reciprocally regulated by arrestin3 and spinophilin. Neuropharmacology 62(7):2354\u20132362. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2012.02.011","journal-title":"Neuropharmacology"},{"issue":"4","key":"1619_CR51","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/npp.2008.184","volume":"34","author":"HT Zhang","year":"2009","unstructured":"Zhang HT, Whisler LR, Huang Y, Xiang Y, O\u2019Donnell JM (2009) Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior. Neuropsychopharmacology 34(4):1067\u20131077. \n                    https:\/\/doi.org\/10.1038\/npp.2008.184","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"1619_CR52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/cne.903280409","volume":"328","author":"AP Nicholas","year":"1993","unstructured":"Nicholas AP, Pieribone V, Hokfelt T (1993) Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328(4):575\u2013594. \n                    https:\/\/doi.org\/10.1002\/cne.903280409","journal-title":"J Comp Neurol"},{"issue":"10","key":"1619_CR53","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.neubiorev.2012.07.011","volume":"36","author":"C Cottingham","year":"2012","unstructured":"Cottingham C, Wang Q (2012) alpha2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy. Neurosci Biobehav Rev 36(10):2214\u20132225. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2012.07.011","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"1619_CR54","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/sj.mp.4001067","volume":"7","author":"J Gonzalez-Maeso","year":"2002","unstructured":"Gonzalez-Maeso J, Rodriguez-Puertas R, Meana JJ, Garcia-Sevilla JA, Guimon J (2002) Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors. Mol Psychiatry 7(7):755\u2013767. \n                    https:\/\/doi.org\/10.1038\/sj.mp.4001067","journal-title":"Mol Psychiatry"},{"issue":"3","key":"1619_CR55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0893-133X(00)00111-1","volume":"23","author":"RA Avery","year":"2000","unstructured":"Avery RA, Franowicz JS, Studholme C, van Dyck CH, Arnsten AF (2000) The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharmacology 23(3):240\u2013249. \n                    https:\/\/doi.org\/10.1016\/S0893-133X(00)00111-1","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1619_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mcn.2011.10.001","volume":"49","author":"WW Ren","year":"2012","unstructured":"Ren WW, Liu Y, Li BM (2012) Stimulation of alpha(2A)-adrenoceptors promotes the maturation of dendritic spines in cultured neurons of the medial prefrontal cortex. Mol Cell Neurosci 49(2):205\u2013216. \n                    https:\/\/doi.org\/10.1016\/j.mcn.2011.10.001","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"1619_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0893-133X(98)00134-1","volume":"21","author":"V Klimek","year":"1999","unstructured":"Klimek V, Rajkowska G, Luker SN, Dilley G, Meltzer HY, Overholser JC, Stockmeier CA, Ordway GA (1999) Brain noradrenergic receptors in major depression and schizophrenia. Neuropsychopharmacology 21(1):69\u201381. \n                    https:\/\/doi.org\/10.1016\/S0893-133X(98)00134-1","journal-title":"Neuropsychopharmacology"},{"key":"1619_CR58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jad.2014.06.016","volume":"167","author":"G Rivero","year":"2014","unstructured":"Rivero G, Gabilondo AM, Garcia-Sevilla JA, La Harpe R, Callado LF, Meana JJ (2014) Increased alpha2- and beta1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment. J Affect Disord 167:343\u2013350. \n                    https:\/\/doi.org\/10.1016\/j.jad.2014.06.016","journal-title":"J Affect Disord"},{"issue":"11","key":"1619_CR59","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.biopsych.2009.12.003","volume":"67","author":"JC Chuang","year":"2010","unstructured":"Chuang JC, Krishnan V, Yu HG, Mason B, Cui H, Wilkinson MB, Zigman JM, Elmquist JK et al (2010) A beta3-adrenergic-leptin-melanocortin circuit regulates behavioral and metabolic changes induced by chronic stress. Biol Psychiatry 67(11):1075\u20131082. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2009.12.003","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1619_CR60","first-page":"246","volume":"271","author":"JM O\u2019Donnell","year":"1994","unstructured":"O\u2019Donnell JM, Frith S, Wilkins J (1994) Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol. J Pharmacol Exp Ther 271(1):246\u2013254","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"1619_CR61","first-page":"67","volume":"46","author":"V Klimek","year":"1994","unstructured":"Klimek V, Papp M (1994) The effect of MK-801 and imipramine on beta-adrenergic and 5-HT2 receptors in the chronic mild stress model of depression in rats. Pol J Pharmacol 46(1\u20132):67\u201369","journal-title":"Pol J Pharmacol"},{"key":"1619_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18433\/J3W31F","volume":"20","author":"N Firouzabadi","year":"2017","unstructured":"Firouzabadi N, Raeesi R, Zomorrodian K, Bahramali E, Yavarian I (2017) Beta adrenoceptor polymorphism and clinical response to sertraline in major depressive patients. J Pharm Pharm Sci 20:1\u20137. \n                    https:\/\/doi.org\/10.18433\/J3W31F","journal-title":"J Pharm Pharm Sci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1619-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1619-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1619-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:11:14Z","timestamp":1588374674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1619-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1619"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1619-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}